Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00515398 · ClinicalTrials.gov registry record
A Study to Evaluate the Effects of Pharmacological Chaperones in Cells From Patients With Pompe Disease
A clinical trial, sponsored by Amicus Therapeutics.
- Completed
- Registry status
- 30
- Enrollment target
NCT00515398 is a clinical trial that has completed, run by Amicus Therapeutics. The registered enrollment target is 30 participants.
The verdict
NCT00515398 has completed, sponsored by Amicus Therapeutics.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to see how molecules called pharmacological chaperones affect the cells of patients with Pompe disease. The study will last 1 or 2 visits which will include a blood collection, urine collection, and two skin biopsies. Information will also be collected from the medical records about disease history and diagnosis. Patients will not receive any study medication.
Interventions
- OTHER Observation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2007-08 |
| Est. Completion | 2008-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00515398
The ClinicalTrials.gov registry entry for NCT00515398 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Amicus Therapeutics, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Observation is the first listed.
NCT00515398 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00515398 about?
NCT00515398 is a clinical study titled "A Study to Evaluate the Effects of Pharmacological Chaperones in Cells From Patients With Pompe Disease". The purpose of this study is to see how molecules called pharmacological chaperones affect the cells of patients with Pompe disease. The study will last 1 or 2 visits which will include a blood collection, urine collection, and two skin biopsies. Information will also be collected from the medical r...
What is the current status of trial NCT00515398?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2007-08. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00515398?
The interventions under investigation include: Observation (OTHER).
Who is sponsoring clinical trial NCT00515398?
This trial is sponsored by Amicus Therapeutics, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.